Similarly, our data showed that, in the overall acromegaly cohort, hormonal levels at diagnosis were not associated with worse cardiac outcomes at the time of CMR analysis; nevertheless, we observed a trend towards higher IGF1xULN levels at diagnosis in patients with active disease compared to the ones in remission at the time of study enrolment: although this difference did not reach statistical significance, likely due to the small sample size, these results would suggest a potential impact of pre-diagnosis disease severity on the development of cardiac abnormalities.
← all excerpts
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study.
1
—
—